Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial

Scope Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease with poor therapeutic strategies. Mastiha possesses antioxidant/anti‐inflammatory and lipid‐lowering properties. The authors investigate the effectiveness of Mastiha as a nonpharmacological intervention in NAFLD. Methods...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular nutrition & food research 2021-05, Vol.65 (10), p.e2001178-n/a, Article 2001178
Hauptverfasser:	Amerikanou, Charalampia, Kanoni, Stavroula, Kaliora, Andriana C., Barone, Angela, Bjelan, Mladen, D'Auria, Giuseppe, Gioxari, Aristea, Gosalbes, María José, Mouchti, Sofia, Stathopoulou, Maria G., Soriano, Beatriz, Stojanoski, Stefan, Banerjee, Rajarshi, Halabalaki, Maria, Mikropoulou, Eleni V., Kannt, Aimo, Lamont, John, Llorens, Carlos, Marascio, Fernando, Marascio, Miriam, Roig, Francisco J., Smyrnioudis, Ilias, Varlamis, Iraklis, Visvikis‐Siest, Sophie, Vukic, Milan, Milic, Natasa, Medic‐Stojanoska, Milica, Cesarini, Lucia, Campolo, Jonica, Gastaldelli, Amalia, Deloukas, Panos, Trivella, Maria Giovanna, Francino, M. Pilar, Dedoussis, George V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antioxidants Cholic acid Clinical trials Dysbacteriosis Fatty liver Fibrosis Food Science & Technology Inflammation Intestinal microflora Life Sciences Life Sciences & Biomedicine Lipids Liver Liver diseases Magnetic resonance imaging Mastiha Metabolites Metabolomics Microbiota microbiota dysbiosis MRI NAFLD/NASH Patients Placebos Science & Technology Supplements
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!